Cullinan Therapeutics CGEM
NASDAQ CGEM
$15.49 +0.96 (+6.61%)
As of: Oct 2, 2026 · 3:55 PM EDT

Cullinan Therapeutics (CGEM) Price to Earnings (2022 - 2023)

Updated

Cullinan Therapeutics' (CGEM) Price to Earnings was 6.16 for Q1 2023, up 41.8% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Price to Earnings (2022 - 2023) Analysis & Trends

For FY2022, Price to Earnings at Cullinan Therapeutics was 4.34.

  • Per Business Quant data, the three quarters before Q1 2023 came in at 4.34 (Q4 2022), 5.56 (Q3 2022) and 5.15 (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Cullinan Therapeutics 987.71 Mn 987.71 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 6.16
Dec 31, 2022 4.34
Sep 30, 2022 5.56
Jun 30, 2022 5.15
API Access

Cullinan Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=CGEM&period=max&api_key=YOUR_API_KEY